Cardiol Therapeutics, Inc. (CRDL.TO)
1.40
-0.07
(-4.76%)
CAD |
TSX |
Dec 15, 16:00
Cardiol Therapeutics EPS Diluted (Quarterly): -0.1176 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Biocure Technology, Inc. | -0.0029 |
| Core One Labs, Inc. | -- |
| Restart Life Sciences Corp. | -0.0059 |
| NanoSphere Health Sciences, Inc. | -0.0013 |
| Lobe Sciences Ltd. | -0.0051 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -9.964M |
| Total Expenses (Quarterly) | 9.964M |
| Enterprise Value | 128.51M |
| Earnings Yield | -29.93% |
| Normalized Earnings Yield | -29.93 |